F-Prime Capital is a venture capital firm investing in healthcare and technology.
F-Prime's roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, this venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx.Today, F-Prime's funds are larger and more global, but its teams are still small and local. F-Prime stays true to its entrepreneurial roots. In the US and Europe, F-Prime Capital Partners is investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, its sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together F-Prime brings a world of insight, domain expertise and relationships to support entrepreneurs. Without the pressure of fundraising from outside investors, F-Prime Capital Partners focuses all of its time finding and helping great entrepreneurs build important companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 27, 2022
Canary Technologies
|
Series B | $30M | Enterprise Software | — |
Oct 25, 2022
ConnexPay
|
Private Equity(PE) | $110M | E-Commerce | — |
Oct 11, 2022
Neumora Therapeutics
|
Series B | $112M | Biotechnology | — |
Sep 13, 2022
Hone
|
Series B | $30M | Business Development | — |
Mar 3, 2022
Ashby
|
Series B | $21.50M | Human Resources | Yes |